Mistaken information. please delete
Header Leaderboard Ad
Collapse
The End for 454
Collapse
Announcement
Collapse
No announcement yet.
X
-
Hi Aniki,
We are committed to providing our 454 instruments, parts, reagents, consumables, service and support for all our 454 products currently on the market over the next three years until mid-2016. We will also be offering new updates, including longer reads for the GS Junior System (both random fragment and amplicon libraries),
If you have any specific questions or concerns I encourage you to reach out to your local Roche service representative.
Best Regards,
Nicole
Senior Support Specialist
454 Life Sciences, A Roche Company
Latest Articles
Collapse
-
by seqadmin
Cancer research has been transformed through numerous molecular techniques, with RNA sequencing (RNA-seq) playing a crucial role in understanding the complexity of the disease. Maša Ivin, Ph.D., Scientific Writer at Lexogen, and Yvonne Goepel Ph.D., Product Manager at Lexogen, remarked that “The high-throughput nature of RNA-seq allows for rapid profiling and deep exploration of the transcriptome.” They emphasized its indispensable role in cancer research, aiding in biomarker...-
Channel: Articles
09-07-2023, 11:15 PM -
-
by seqadmin
Ribonucleic acid (RNA) represents a range of diverse molecules that play a crucial role in many cellular processes. From serving as a protein template to regulating genes, the complex processes involving RNA make it a focal point of study for many scientists. This article will spotlight various methods scientists have developed to investigate different RNA subtypes and the broader transcriptome.
Whole Transcriptome RNA-seq
Whole transcriptome sequencing...-
Channel: Articles
08-31-2023, 11:07 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 09-22-2023, 09:05 AM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-22-2023, 09:05 AM
|
||
Started by seqadmin, 09-21-2023, 06:18 AM
|
0 responses
12 views
0 likes
|
Last Post
by seqadmin
09-21-2023, 06:18 AM
|
||
Started by seqadmin, 09-20-2023, 09:17 AM
|
0 responses
13 views
0 likes
|
Last Post
by seqadmin
09-20-2023, 09:17 AM
|
||
Started by seqadmin, 09-19-2023, 09:23 AM
|
0 responses
28 views
0 likes
|
Last Post
by seqadmin
09-19-2023, 09:23 AM
|
Comment